Toxins News and Research

RSS

Some bacteria cells get hangry too, study finds

Have you ever been so hungry that you become angry, otherwise known as "hangry?" New research by Adam Rosenthal, PhD, assistant professor in the Department of Microbiology and Immunology, has found that some bacteria cells get hangry too, releasing harmful toxins into our bodies and making us sick.

3 Apr 2023

Probiotic E. coli secretes proteins of therapeutic value into its surroundings

Humans are colonized with thousands of bacterial strains. Researchers are now focused on genetically modifying such bacteria to enhance their intrinsic therapeutic properties.

31 Mar 2023

Manipulating blood flow in the brain with visual stimulation induces complementary fluid flow

Researchers at Boston University, USA report that the flow of cerebrospinal fluid in the brain is linked to waking brain activity.

31 Mar 2023

Pneumolysin toxin holds promise for developing therapies against Streptococcus pneumoniae

In a recent study published in the journal PLoS ONE, researchers in Spain performed a systematic review of pneumolysin (PLY) toxin as a molecular target to develop novel therapeutics against Streptococcus pneumoniae.

27 Mar 2023

Zoonotic agent Erysipelothrix rhusiopathiae caused mass mortality of harbor porpoises

In a recent article published in the Emerging Infectious Diseases Journal, researchers in the Netherlands described a mortality event that killed hundreds of harbor porpoises (Phocoena phocoena), a small cetacean, along the Netherlands coastline, in August 2021.

22 Mar 2023

Why are colon cancer rates in young people rising?

In a recent perspective article published in the journal Science, researchers at the Young-Onset Colorectal Cancer Center of Dana-Farber Cancer Institute emphasized that a better understanding of the etiology of early-onset colorectal cancer (EOCRC) is crucial to managing its increasing incidence worldwide

21 Mar 2023

The role of the fungal mycobiome in women's health

Researchers discuss the association between human mycobiota and female health.

15 Mar 2023

The relationship between intestinal microbiome dysbiosis and atherosclerosis

Researchers investigate the impact of intestinal microbiota dysbiosis on atherosclerotic cardiovascular disease incidence.

15 Mar 2023

The burden of Clostridioides difficile infections in the United States

Researchers review existing data on Clostridioides difficile infections among United States residents.

13 Mar 2023

Study suggests a new way to develop intra-tumor immunotherapies to fight head and neck cancer

Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health have identified a strong association between the product of a gene expressed in most cancers, including the most common type of head and neck cancer, and elevated levels of white blood cells that produce antibodies within tumors.

13 Mar 2023

Researchers receive PCORI funding to study the effectiveness of individualized model of hemodialysis

The Patient-Centered Outcomes Research Institute (PCORI) recently awarded researchers at Wake Forest University School of Medicine $10.2 million to study the effectiveness of an individualized model of hemodialysis, a procedure in which the blood is cleaned by a dialysis machine.

9 Mar 2023

Evaluating how bacterial therapeutics may synergize with existing anti-cancer therapies

It may come as a surprise, but bacteria love to grow inside tumors. It's the environment-;tumors are typically acidic, have low amounts of oxygen, and are filled with dead cells, which all facilitate bacterial growth.

6 Mar 2023

Modifying gut flora before surgery could reduce postoperative complications in colorectal cancer patients

In a promising study, Canadian researchers have shown for the first time in mice that modifying intestinal flora before surgery could reduce postoperative complications in colorectal cancer patients.

1 Mar 2023

Immunomodulatory effects of biotics-supplemented infant formulas

A review article published in the journal Nutrients describes the effects and benefits of pre-, pro-, syn-, and postbiotics-containing infant formulas in terms of modulating gut microbiota, immune response, and allergy susceptibility of newborns and infants.

1 Mar 2023

Toxins News and Research

Some bacteria cells get hangry too, study finds

Probiotic E. coli secretes proteins of therapeutic value into its surroundings

Manipulating blood flow in the brain with visual stimulation induces complementary fluid flow

Pneumolysin toxin holds promise for developing therapies against Streptococcus pneumoniae

Zoonotic agent Erysipelothrix rhusiopathiae caused mass mortality of harbor porpoises

Why are colon cancer rates in young people rising?

The role of the fungal mycobiome in women's health

The relationship between intestinal microbiome dysbiosis and atherosclerosis

The burden of Clostridioides difficile infections in the United States

Study suggests a new way to develop intra-tumor immunotherapies to fight head and neck cancer

Researchers receive PCORI funding to study the effectiveness of individualized model of hemodialysis

Evaluating how bacterial therapeutics may synergize with existing anti-cancer therapies

Modifying gut flora before surgery could reduce postoperative complications in colorectal cancer patients

Immunomodulatory effects of biotics-supplemented infant formulas

Bacteria exploit nerve cells in the meninges to facilitate brain invasion

Scientists working to create revolutionary biocomputers powered by brain organoids

Tiny worm enables scientists to explore the theory that Parkinson's disease starts in the gut

Using sweat to diagnosis disease: soft microfluidic analysis systems assess health status

NQO2 gene as a novel potential target in Parkinson’s disease

New prototype treatment proves effective against the venom of African and Asian elapid snakes

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News